In an interview with Ars Technica in August, Brigid Groves, vice president of professional affairs for the American Pharmacists Association (APhA) signaled that efforts to limit access to COVID-19 vaccines is concerning to APhA, which is the leading organization representing pharmacists.
“We are concerned about that because the data and evidence point to the fact that this vaccine is safe and effective for [young, otherwise healthy] patients,” Groves said. “So, to suddenly arbitrarily limit that is very concerning to us.”
And, with the CDC’s permissive recommendations, pharmacies are not limiting them. Representatives for both CVS and Walgreens told The Washington Post that they would not require patients under 65
→ Continue reading at Ars Technica